| Primary |
| Type 2 Diabetes Mellitus |
69.7% |
| Type Ii Diabetes Mellitus |
11.7% |
| Type 2 Diabetes Mellitus |
4.9% |
| Diabetes Mellitus |
4.2% |
| Drug Use For Unknown Indication |
4.2% |
| Type Ii Diabetes Mellitus |
2.0% |
| Diabetes |
1.0% |
| Type Ii Diabetes |
1.0% |
| Depression |
0.3% |
| Glucose Tolerance Impaired |
0.3% |
| Insulin-requiring Type Ii Diabetes Mellitus |
0.3% |
| Product Used For Unknown Indication |
0.3% |
|
| Bladder Cancer |
67.1% |
| Metastatic Carcinoma Of The Bladder |
4.5% |
| Renal Cancer |
3.7% |
| Prostate Cancer |
2.8% |
| Urinary Tract Infection |
2.8% |
| Myocardial Infarction |
2.0% |
| Ureteric Cancer |
2.0% |
| Bladder Disorder |
1.6% |
| Bladder Transitional Cell Carcinoma |
1.6% |
| Metastases To Bone |
1.6% |
| Renal Failure |
1.6% |
| Bladder Papilloma |
1.2% |
| Renal Disorder |
1.2% |
| Weight Increased |
1.2% |
| Bladder Cancer Recurrent |
0.8% |
| Bone Cancer Metastatic |
0.8% |
| Cerebrovascular Accident |
0.8% |
| Haematuria |
0.8% |
| Interstitial Lung Disease |
0.8% |
| Metastases To Lymph Nodes |
0.8% |
|
| Secondary |
| Product Used For Unknown Indication |
29.7% |
| Type 2 Diabetes Mellitus |
24.3% |
| Type 2 Diabetes Mellitus |
16.2% |
| Diabetes Mellitus |
13.5% |
| Drug Use For Unknown Indication |
8.1% |
| Drug Use For Unknown Indication |
2.7% |
| Hyperlipidaemia |
2.7% |
| Type Ii Diabetes Mellitus |
2.7% |
|
| Renal Failure Acute |
18.2% |
| Bladder Cancer |
9.1% |
| Blood Glucose Increased |
9.1% |
| Diabetes Mellitus Inadequate Control |
9.1% |
| Malaise |
9.1% |
| Red Blood Cell Count Decreased |
9.1% |
| Renal Impairment |
9.1% |
| Rhabdomyolysis |
9.1% |
| Syncope |
9.1% |
| Vomiting |
9.1% |
|
| Concomitant |
| Type 2 Diabetes Mellitus |
48.8% |
| Prostate Cancer Metastatic |
9.3% |
| Nephrogenic Anaemia |
7.0% |
| Product Used For Unknown Indication |
7.0% |
| Type Iia Hyperlipidaemia |
4.7% |
| Diabetes Mellitus |
2.3% |
| Huntington's Disease |
2.3% |
| Iron Deficiency Anaemia |
2.3% |
| Myelodysplastic Syndrome |
2.3% |
| Narcolepsy |
2.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.3% |
| Prostate Infection |
2.3% |
| Renal Cancer |
2.3% |
| Schizophrenia |
2.3% |
| Thyroid Cancer |
2.3% |
|
| Pancreatitis |
23.3% |
| Blood Glucose Decreased |
6.7% |
| Blood Glucose Increased |
6.7% |
| Pancreatitis Acute |
6.7% |
| Weight Decreased |
6.7% |
| Anxiety |
3.3% |
| Death |
3.3% |
| Disease Progression |
3.3% |
| Diverticulitis |
3.3% |
| Dyspnoea |
3.3% |
| Gastrointestinal Haemorrhage |
3.3% |
| Hypersensitivity |
3.3% |
| Hypertransaminasaemia |
3.3% |
| Hypoglycaemic Coma |
3.3% |
| Loss Of Consciousness |
3.3% |
| Nasopharyngitis |
3.3% |
| Off Label Use |
3.3% |
| Pollakiuria |
3.3% |
| Renal Disorder |
3.3% |
| Renal Failure |
3.3% |
|
